Canadian Market Access Advisory
Senior expertise. Canadian payer insight. Practical access strategy.
We provide senior-level market access, payer and pricing advisory support to pharmaceutical and biotech companies navigating the Canadian healthcare system.
We know what matters to Canadian payers
Our work helps clients understand what matters to Canadian payers and HTA bodies, anticipate access challenges, strengthen value narratives, and make informed decisions throughout the product lifecycle.
We bring deep Canadian market access experience across CADTH, INESSS, provincial drug plans, private payers, pricing, and reimbursement, combined with a practical understanding of how evidence, clinical value, pricing and payer decision-making intersect.
We work alongside internal market access, HEOR, medical and commercial teams, and where appropriate alongside larger consultancies, to provide focused senior expertise where it adds the most value.
What We Do
Six areas of senior support
Focused senior expertise across the questions that decide Canadian access.
Market Access Strategy
Practical, payer-informed access strategies built for the Canadian market.
Read morePayer & HTA Advisory
Strategic insight into how CADTH, INESSS, provincial plans and private payers are likely to view a product.
Read moreEvidence & Value Strategy
Identifying and communicating the evidence most relevant to reimbursement decision-making.
Read morePayer & Stakeholder Research
Focused payer and HTA research designed to answer a specific market access question.
Read moreHTA Strategy & Submission Direction
Senior strategic guidance and challenge for CADTH, INESSS and provincial submissions.
Read morePricing & Reimbursement
The relationship between pricing, evidence, clinical value and Canadian reimbursement expectations.
Read moreTechnology & AI
Turning market access strategy into digital solutions.
Market access teams work with growing volumes of evidence, payer intelligence, HTA decisions and pricing data. We combine market access expertise with software development and applied AI to turn that information into practical, scalable tools, from rapid prototypes to fully developed platforms.
Technology & AI solutionsHTA intelligence
Make historical HTA decisions and precedents searchable.
Evidence review
Accelerate identification, screening and synthesis.
Rapid prototyping
Test an idea in days rather than quarters.
Our Approach
Senior expertise without the layers
Market access decisions are often complex, but the advice clients receive should not be. You work directly with senior market access and payer experts, not a large team of junior consultants.
How we workStrategic
We focus on the decisions that will affect access, not simply on producing deliverables.
Payer-informed
Practical understanding of how Canadian public and private payers and HTA bodies assess value.
Evidence-driven
We connect clinical, economic and real-world evidence to the questions that matter for reimbursement.
Pragmatic
Strategies need to work within real-world evidence, timing, resource and commercial constraints.
Collaborative
We work as an extension of your team and can complement internal capabilities or larger consulting partners.
Meet the Advisors
Two perspectives. One integrated view of access.
Shannon Lee
Market Access Strategy & Payer Advisory
More than 15 years supporting pharmaceutical and biotech companies across market access strategy, HTA, payer engagement and reimbursement.
Full profileMarc Godard
Market Access Technology & AI
Builds the software and AI tools behind the practice, turning market access problems into working platforms and prototypes.
Full profileTell us what you are trying to solve.
Whether you are preparing for a Canadian launch, developing an HTA strategy, assessing pricing and reimbursement, or looking for an independent payer perspective, we can provide focused senior-level support.
Canadian Market Access Advisory
Senior market access, payer and pricing advisory for pharmaceutical and biotech companies navigating the Canadian healthcare system.
